The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting genetic instructions from DNA and creating proteins. With the power to execute a ...

Tech billionaire investor Bill Gates was given approval to "secretly" spray synthetic RNA on food products in the United States through a company called Terrana Biosciences. One Facebook post ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology ...

Penn Commons at the University of Pennsylvania (Mark Henninger/Imagic Digital) Cellular-level biology that could help develop vaccines just got more accessible to researchers, thanks to AI. The ...

< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...

MONTREAL--(BUSINESS WIRE)--AmorChem II Fund L.P. (''AmorChem'') is delighted to announce that its RNA Zipcode delivery program has been acquired by Kodikaz Therapeutic Solutions, Inc. (''Kodikaz''), a ...